Eiseki Usami

611 total citations
72 papers, 470 citations indexed

About

Eiseki Usami is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Eiseki Usami has authored 72 papers receiving a total of 470 indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Oncology, 25 papers in Pulmonary and Respiratory Medicine and 9 papers in Epidemiology. Recurrent topics in Eiseki Usami's work include Colorectal Cancer Treatments and Studies (23 papers), Gastric Cancer Management and Outcomes (14 papers) and Cancer Treatment and Pharmacology (12 papers). Eiseki Usami is often cited by papers focused on Colorectal Cancer Treatments and Studies (23 papers), Gastric Cancer Management and Outcomes (14 papers) and Cancer Treatment and Pharmacology (12 papers). Eiseki Usami collaborates with scholars based in Japan and United States. Eiseki Usami's co-authors include Tomoaki Yoshimura, Michio Kimura, Hitomi Teramachi, Hiroyuki Tanaka, Hiroichi Nagai, Hiroichi Nagai, Naoki Inagaki, H. Nagai, Teizo Yoshimura and Hiroki Asano and has published in prestigious journals such as International Journal of Cancer, Supportive Care in Cancer and Biological and Pharmaceutical Bulletin.

In The Last Decade

Eiseki Usami

64 papers receiving 453 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eiseki Usami Japan 12 159 135 78 60 50 72 470
Chris Fellner United States 12 110 0.7× 70 0.5× 132 1.7× 73 1.2× 74 1.5× 24 505
Yun‐Ching Huang Taiwan 16 68 0.4× 95 0.7× 176 2.3× 28 0.5× 35 0.7× 43 672
Lukas Haragsim United States 9 72 0.5× 62 0.5× 166 2.1× 43 0.7× 52 1.0× 19 542
Konosuke Konishi Japan 13 83 0.5× 64 0.5× 130 1.7× 125 2.1× 43 0.9× 36 591
Yongqiang Zheng China 17 169 1.1× 96 0.7× 156 2.0× 78 1.3× 17 0.3× 43 551
Jiandong Zhang China 14 80 0.5× 50 0.4× 132 1.7× 134 2.2× 83 1.7× 22 651
M Broggini Italy 14 180 1.1× 97 0.7× 133 1.7× 28 0.5× 101 2.0× 43 724
Margaret Salfi United States 13 109 0.7× 96 0.7× 63 0.8× 36 0.6× 18 0.4× 19 547
Xiaoxi Zhang China 13 73 0.5× 40 0.3× 136 1.7× 76 1.3× 36 0.7× 19 572
Chao Fan China 13 93 0.6× 132 1.0× 163 2.1× 150 2.5× 29 0.6× 26 592

Countries citing papers authored by Eiseki Usami

Since Specialization
Citations

This map shows the geographic impact of Eiseki Usami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eiseki Usami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eiseki Usami more than expected).

Fields of papers citing papers by Eiseki Usami

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eiseki Usami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eiseki Usami. The network helps show where Eiseki Usami may publish in the future.

Co-authorship network of co-authors of Eiseki Usami

This figure shows the co-authorship network connecting the top 25 collaborators of Eiseki Usami. A scholar is included among the top collaborators of Eiseki Usami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eiseki Usami. Eiseki Usami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Noguchi, Yoshihiro, et al.. (2024). Association between CDK4/6 inhibitors and drug‐related osteonecrosis of the jaw: A pharmacoepidemiological study using the FDA Adverse Events Reporting System. International Journal of Cancer. 155(5). 849–853. 6 indexed citations
3.
4.
Oida, Yasuhisa, et al.. (2024). Exploring Points of Operating Room Pharmacist Intervention Based on Evaluation of Appropriate Use of Perioperative Antimicrobial Agents in Colorectal Surgery. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 50(6). 287–293.
5.
6.
Matsuoka, Tomoko, et al.. (2024). Impact of pharmacist-led aminoglycoside stewardship: a 10-year observational study. Journal of Pharmaceutical Health Care and Sciences. 10(1). 77–77.
7.
8.
Asano, Hiroki, Yoshihiro Noguchi, Michio Kimura, Eiseki Usami, & Tomoaki Yoshimura. (2023). Pituitary-Related Adverse Events and Onset Patterns Caused by Immune Checkpoint Inhibitors: Analysis Using the Japanese Adverse Drug Event Report Database. Medicina. 59(11). 1963–1963. 2 indexed citations
9.
Kimura, M, Eiseki Usami, Hitomi Teramachi, & Tomoaki Yoshimura. (2020). Identifying optimal magnesium replenishment points based on risk of severe hypomagnesemia in colorectal cancer patients treated with cetuximab or panitumumab. Cancer Chemotherapy and Pharmacology. 86(3). 383–391. 6 indexed citations
10.
Kimura, Masashi, et al.. (2018). Prognostic factors in patients with advanced and recurrent colorectal cancer receiving last-line chemotherapy.. PubMed. 73(2). 115–119. 7 indexed citations
11.
Kimura, Michio, et al.. (2017). Pharmaco-economic analysis of adjuvant chemotherapy for stage II and III colorectal cancer. Molecular and Clinical Oncology. 6(5). 794–798. 1 indexed citations
12.
Kimura, Michio, et al.. (2017). Usefulness of a pharmacist outpatient service for S-1 adjuvant chemotherapy in patients with gastric cancer. Molecular and Clinical Oncology. 7(3). 486–492. 13 indexed citations
13.
Usami, Eiseki, et al.. (2016). [Treatment Continuation and Safety of Eribulin for the Treatment of Metastatic Breast Cancer].. PubMed. 43(13). 2513–2516. 1 indexed citations
14.
Kimura, Michio, et al.. (2016). Neutropenia as a prognostic factor and safety of second-line therapy with S-1 for advanced or recurrent pancreatic cancer. Molecular and Clinical Oncology. 5(3). 283–288. 4 indexed citations
15.
Kimura, Michio, Eiseki Usami, Tomoaki Yoshimura, et al.. (2014). Safety and continuity of second- and third-line therapy with paclitaxel or irinotecan for advanced and recurrent gastric cancer. Molecular and Clinical Oncology. 2(3). 466–472. 3 indexed citations
16.
Kimura, Michio, Eiseki Usami, Tomoaki Yoshimura, et al.. (2014). Oral anticancer agent medication adherence by outpatients. Oncology Letters. 8(5). 2318–2324. 13 indexed citations
17.
Kimura, Michio, et al.. (2007). Analysis of Adverse Reactions in Cancer Chemotherapy-Constipation Occurring with Co-administration of Anticancer Agents and 5-HT3 Antagonists-. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 33(10). 863–868. 2 indexed citations
18.
Yoshimura, Tomoaki, et al.. (2007). Evaluation of Safety of FOLFOX4 Regimen in Patients with Advanced and Recurrent Colorectal Cancer. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 33(6). 520–525. 2 indexed citations
19.
20.
Yoshimura, Tomoaki, et al.. (1996). Immunomodulatory Action of Levofloxacin on Cytokine Production by Human Peripheral Blood Mononuclear Cells. Chemotherapy. 42(6). 459–464. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chris Fellner Breakdown of academic impact, for papers by Yun‐Ching Huang Breakdown of academic impact, for papers by Lukas Haragsim Breakdown of academic impact, for papers by Konosuke Konishi Breakdown of academic impact, for papers by Yongqiang Zheng Breakdown of academic impact, for papers by Jiandong Zhang Breakdown of academic impact, for papers by M Broggini Breakdown of academic impact, for papers by Margaret Salfi Breakdown of academic impact, for papers by Xiaoxi Zhang Breakdown of academic impact, for papers by Chao Fan
Rankless by CCL
2026